[HTML][HTML] Treatment options in obstructive sleep apnea

F Gambino, MM Zammuto, A Virzì, G Conti… - Internal and emergency …, 2022 - Springer
Abstract Treatment of OSA with CPAP is currently the recommended treatment and has the
greatest evidence of efficacy on AHI, symptoms and comorbidities. Symptomatic patients …

[HTML][HTML] Perspective: Systematic review and meta-analysis in obstructive sleep apnea–What is lacking?

D Lisik, GN Pires, D Zou - Sleep Medicine, 2023 - Elsevier
Obstructive sleep apnea (OSA) affects nearly one billion of the global adult population. It is
associated with substantial burden in terms of quality of life, cognitive function, and …

Turning over a new leaf—pharmacologic therapy in obstructive sleep apnea

J Hedner, D Zou - Sleep Medicine Clinics, 2022 - sleep.theclinics.com
Obstructive sleep apnea (OSA) is a common condition that has turned out to provide a
challenge for physicians and the health-care systems. 1 This particular form of sleep …

Comparison of clinical pathways for hypoglossal nerve stimulation management: in-laboratory titration polysomnography vs home-based efficacy sleep testing

D Kent, P Huyett, P Yu, A Roy, R Mehra… - Journal of Clinical …, 2023 - jcsm.aasm.org
Study Objectives: We conducted this study to evaluate whether laboratory or home-based
hypoglossal nerve stimulation (HNS) management would have equivalent objective and …

Cluster analysis of upper airway stimulation adherence patterns and implications on clinical care

RJ Soose, M Araujo, K Faber, A Roy, K Lee, Q Ni… - Sleep, 2022 - academic.oup.com
Abstract Study Objectives Upper airway stimulation (UAS) therapy is effective for a subset of
obstructive sleep apnea (OSA) patients with continuous positive airway pressure (CPAP) …

Personalized multimodal management for severe obstructive sleep apnea in a patient intolerant of positive airway pressure with hypoglossal nerve stimulator and …

MM Lowery, JV Rundo, HK Walia… - Journal of Clinical Sleep …, 2023 - jcsm.aasm.org
Treatment of moderate to severe obstructive sleep apnea poses clinical challenges in
persons with intolerance or inadequate response to traditional treatment modalities …

[HTML][HTML] Dynamics of circulating CD14/CD16 monocyte subsets in obstructive sleep apnea syndrome patients upon hypoglossal nerve stimulation

R Pries, C Lange, N Behn, KL Bruchhage, A Steffen - Biomedicines, 2022 - mdpi.com
Background: Obstructive sleep apnea syndrome (OSAS) is a widespread respiratory
disease that is associated with recurrent breathing intermissions at night. The corresponding …

Increased body mass index correlates with less favorable postoperative outcomes after hypoglossal nerve stimulation for obstructive sleep apnea: a retrospective …

F Corr, F Kilinç, J Oros, LE Qasem, A Al-Hilou… - World Neurosurgery, 2023 - Elsevier
Objective Obstructive sleep apnea is associated with high morbidity. Hypoglossal nerve
stimulation (HNS) has become a novel (neuro-) surgical treatment strategy for obstructive …

Hypoglossal Nerve Stimulation Therapy in a Belgian Cohort of Obstructive Sleep Apnea Patients

D Van Loo, M Dieltjens, S Engelen, J Verbraecken… - Life, 2024 - mdpi.com
Hypoglossal nerve stimulation (HGNS) has emerged as a widespread and innovative
treatment option for selected moderate-to-severe obstructive sleep apnea patients who …

The impact of neck circumference on hypoglossal nerve stimulator therapy outcomes

MJ Hutz, DM Plata, P LoSavio, J Herdegen… - Journal of Clinical …, 2024 - jcsm.aasm.org
Study Objectives: Hypoglossal nerve stimulation (HGNS) therapy has historically had strict
eligibility requirements including a body mass index (BMI)< 32 kg/m2. However, recent Food …